Nakashima M N, Kataoka Y, Yamashita K, Kohzuma M, Ichikawa M, Niwa M, Kohno Y, Taniyama K
Department of Hospital Pharmacy, Nagasaki University School of Medicine, Japan.
Jpn J Pharmacol. 1995 Jan;67(1):91-4. doi: 10.1254/jjp.67.91.
The protective effect of nebracetam on ischemic neuronal damage was histologically examined in the pyramidal cell layer of the hippocampal CA1 subfield 7 days after operation using stroke-prone spontaneously hypertensive rats (SHRSP) subjected to 10-min bilateral carotid occlusion. Nebracetam (50 and 100 mg/kg), given orally 10 min after reperfusion, dose-dependently protected against ischemic delayed neuronal damage in the SHRSP with occlusion; however, the blood pressure remained unchanged following nebracetam administration. These findings further support the notion that nebracetam protects against ischemic delayed neuronal cell death in the hippocampus.
使用易中风自发性高血压大鼠(SHRSP),对其进行10分钟的双侧颈动脉闭塞,术后7天在海马CA1亚区锥体细胞层进行组织学检查,以研究奈非西坦对缺血性神经元损伤的保护作用。在再灌注后10分钟口服给予奈非西坦(50和100mg/kg),其对闭塞的SHRSP中的缺血性延迟神经元损伤具有剂量依赖性保护作用;然而,给予奈非西坦后血压保持不变。这些发现进一步支持了奈非西坦可保护海马中缺血性延迟神经元细胞死亡的观点。